Market failure and the poverty of new drugs in maternal health.
Fisk
Nicholas M
NM
Imperial College London, London, United Kingdom. n.fisk@uq.edu.au
Atun
Rifat
R
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D002317:Cardiovascular Agents; D016208:Databases, Factual; D004341:Drug Evaluation / Q000191:economics / Q000706:statistics & numerical data; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics / Q000706:statistics & numerical data*; D015507:Drugs, Investigational; D005060:Europe; D005260:Female; D005378:Financial Support; D006801:Humans; D040541:Marketing / Q000706:statistics & numerical data*; D008429:Maternal Welfare; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012106:Research / Q000191:economics / Q000706:statistics & numerical data; D012306:Risk; D014481:United States
D002317:Cardiovascular Agents; D015507:Drugs, Investigational